Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
The use of intranasal dexmedetomidine for pediatric sedation in non-invasive radiological procedures (CTMS 004321) Assessing the efficacy and safety profile of intranasal dexmedetomidine for procedural sedation in radiological procedures in children with a prospective exploratory interventional monocentric study in a tertiary center in Antwerp (Belgium)
This study looks at a nose spray medicine called dexmedetomidine to help children relax during scans like X-rays. Researchers want to see how well it works and if it's safe for children in Antwerp, Belgium.
For: Sedation in healthy childrenBelgium - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome
This study is looking at different ways to sedate (keep calm) very sick patients in intensive care (ICU) who are at risk of a serious lung condition called ARDS. It compares inhaled sedation with standard methods to see if it helps lung function and overall recovery.
For: Patients in ICU with risks of Acute Respiratory Distress SyndromeFrance - AuthorisedTherapeutic confirmatory (Phase III)
Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: the PEDIADEX randomized controlled trial
This study looks at how a medicine called dexmedetomidine, given first for sleep in the intensive care unit (ICU), affects confusion (delirium) in children. It compares it to another common medicine, midazolam. The main goal is to see if fewer children get confused when given dexmedetomidine.
For: Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care:France